00

Jinling Pharmaceutical Co LtdSHE 000919 Stock Report

Last reporting period 30 Sep, 2023

Updated 01 Nov, 2024

Last price

Market cap $B

0.541

Micro

Exchange

XSHE - Shenzhen Stock Exchange

000919.SZ Stock Analysis

00

Avoid

Based on Eyestock quantitative analysis, 000919.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

42/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

5.9 %

Undervalued

Market cap $B

0.541

Dividend yield

2.88 %

Shares outstanding

511.14 B

Jinling Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 4,865 full-time employees. The Company’s main products include Mailuoning injections, ferrous succinate tablets and Lentinan injection, among others. The firm is also involved in the provision of medical services and the sale of medical instrument. The firm distributes its products in domestic market, with North China as its main market.

View Section: Eyestock Rating